Document is current
Any future updates will be listed below
-
Authors
Lin, Hao-Kuen
Dai, Jiawei
Pusztai, Lajos
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation Investigator Award (BCRF-22-133), Susan Komen Leadership Grant (BCRF-22-133, SAC220225)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 25 August 2025
First Online: 1 September 2025
Declarations
:
: L.P. has received consulting fees and honoraria for advisory board participation from Pfizer, Astra Zeneca, Merck, Bristol-Myers Squibb, Stemline-Menarini, BeOne, Personalis, Natera, Agendia, Exact Sciences, Radionetics, and institutional research funding from Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, and Menarini-Stemline. Stock options in Ataraxis.
